companydata.dkcompanydata.dk

ALFASCAN ApS: Financial statements 2022

CVR: 73171814

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

ALFASCAN ApS (CVR 73171814) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,089,578 and a net result of DKK 484,220 compared with DKK 534,524 the year before. That is a decrease of 6.5% compared with the year before. Equity in the 2022 report amounted to DKK 761,088. The solvency ratio was 22.8%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,089,578
Profit/Loss
DKK 484,220
Equity
DKK 761,088
Total Assets
DKK 3,335,185
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-1.1 mio.484 t.761 t.1
2021-1.2 mio.535 t.777 t.1
2020-1.2 mio.442 t.642 t.1
2019-1.2 mio.408 t.361 t.1
2018-1.2 mio.342 t.542 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ALFASCAN ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

ALFASCAN ApS: The 2021 annual report is outApr 4, 2022

ALFASCAN ApS has published its annual report for 2021. Gross profit came to DKK 1,164,947, and the net result was DKK 534,524.

About ALFASCAN ApS

ALFASCAN ApS is a Danish company of the type Anpartsselskab based in København S, founded in 1983. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MARSING SCANDINAVIA AGENCIES LTD.. ApS. The management consists of René Andersen. The company is owned by LAUFUS HOLDING ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,031,792 and a net result of DKK 424,644 compared with DKK 147,984 the year before. Equity in the 2025 report amounted to DKK 1,326,662.

Source: annual report 2025, Danish Business Authority